TIMOTHY C. RODELL, M.D.

Corporate Board Profile

Tech Score: 0/100

GT Biopharma, Inc.

Filing Date	Source Excerpt
2004-04-29	Timothy C. Rodell, M.D. Age: 53 Director. Dr. Rodell is Chief Executive Officer of GlobeImmune, Inc., an early stage immunotherapy company focused on chronic viral diseases and cancer. ... After the resignations of Messrs. Wolf and Ford Webb, the Board of Directors appointed Dr. Bruinsma and Mr. Neill as new members of this Committee, such that the Committee is currently comprised of Dr. Bruinsma (Chair), Mr. Neill and Dr. Rodell.
2005-04-29	Timothy C. Rodell, M.D. 54 Director Member of the Nominating Committee and the Compensation Committee.

Filing Date

Source Excerpt

2004-04-29

Timothy C. Rodell, M.D. Age: 53 Director. Dr. Rodell is Chief Executive Officer of GlobeImmune, Inc., an early stage immunotherapy company focused on chronic viral diseases and cancer. ... After the resignations of Messrs. Wolf and Ford Webb, the Board of Directors appointed Dr. Bruinsma and Mr. Neill as new members of this Committee, such that the Committee is currently comprised of Dr. Bruinsma (Chair), Mr. Neill and Dr. Rodell.

2005-04-29

Timothy C. Rodell, M.D. 54 Director** ** Member of the Nominating Committee and the Compensation Committee.

Data sourced from SEC filings. Last updated: 2025-10-12